• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 11
      How to keep weight off after obesity drugs - 5 day(s) ago

      Nature – Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.

      Source: www.nature.com
      Categories: General Medicine News, Expert Picks
      Tweet Tweets with this article
      • Profile photo of 	CMichaelGibson
        CMichaelGibson

        How to keep weight off after obesity drugs: Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability. https://t.co/8iwrx68PUp

    • Mashup Score: 10
      How to keep weight off after obesity drugs - 5 day(s) ago

      Nature – Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.

      Source: www.nature.com
      Categories: General Medicine News, Expert Picks
      Tweet Tweets with this article
      • Profile photo of 	CMichaelGibson
        CMichaelGibson

        How to keep weight off after obesity drugs: Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability. https://t.co/8iwrx68PUp

    • Mashup Score: 8
      Metsera’s amylin drug shows early potential for substantial weight loss - 7 day(s) ago

      Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said

      Source: www.statnews.com
      Categories: General Medicine News, Expert Picks
      Tweet Tweets with this article
      • Profile photo of 	CMichaelGibson
        CMichaelGibson

        Metsera amylin drug achieves notable weight loss in Phase 1 trial | STAT https://t.co/z9HQkze7D4

    • Mashup Score: 8
      Metsera’s amylin drug shows early potential for substantial weight loss - 7 day(s) ago

      Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said

      Source: www.statnews.com
      Categories: General Medicine News, Expert Picks
      Tweet Tweets with this article
      • Profile photo of 	CMichaelGibson
        CMichaelGibson

        Metsera amylin drug achieves notable weight loss in Phase 1 trial | STAT https://t.co/z9HQkze7D4

    • Mashup Score: 25
      Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months - 12 day(s) ago

      In the 1980s, atherothrombosis was definitively established as the most prevalent mechanism underlying acute coronary syndromes (ACS).1,2 In the 1990s, sin

      Source: academic.oup.com
      Categories: General Medicine News, Expert Picks
      Tweet Tweets with this article
      • Profile photo of 	CMichaelGibson
        CMichaelGibson

        Great debate: Lots of world class clinicians weigh in on whether the default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months https://t.co/FEKDxiZeNC

    • Mashup Score: 19
      FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People - 13 day(s) ago

      FDA Launches Agency-Wide AI Tool

      Source: www.fda.gov
      Categories: General Medicine News, Expert Picks
      Tweet Tweets with this article
      • Profile photo of 	CMichaelGibson
        CMichaelGibson

        FDA launches Elsa, an AI tool to help employees work more efficiently by accelerating clinical protocol reviews, shorten the time needed for scientific evaluations, and identifying high-priority inspection targets. https://t.co/zeCypSj0Yj

    • Mashup Score: 15
      Breast Cancer Patients Get Early Warning of Faltering Drugs With Blood Test - 14 day(s) ago

      A study found that women could switch drugs without waiting for scans showing cancer progression, which improved their quality of life.

      Source: www.nytimes.com
      Categories: General Medicine News, Expert Picks
      Tweet Tweets with this article
      • Profile photo of 	CMichaelGibson
        CMichaelGibson

        Drug-Defying Breast Cancers Spotted Early in Blood Test Study A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved their quality of life. https://t.co/jiDsPJshea

    • Mashup Score: 8
      Pew Finds BlueSky's 'News Influencers' Aren't Influencing Anyone - 14 day(s) ago

      “Even with Bluesky’s growth, X remains popular…” 

      Source: www.zerohedge.com
      Categories: General Medicine News, Expert Picks
      Tweet Tweets with this article
      • Profile photo of 	CMichaelGibson
        CMichaelGibson

        https://t.co/Agu7o7r4F3 https://t.co/HhjjzJjyPN

    • Mashup Score: 19
      FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People - 14 day(s) ago

      FDA Launches Agency-Wide AI Tool

      Source: www.fda.gov
      Categories: General Medicine News, Expert Picks
      Tweet Tweets with this article
      • Profile photo of 	CMichaelGibson
        CMichaelGibson

        FDA launches Elsa, an AI tool to help employees work more efficiently by accelerating clinical protocol reviews, shorten the time needed for scientific evaluations, and identifying high-priority inspection targets. https://t.co/zeCypSj0Yj

    • Mashup Score: 24
      Outcomes of Coronary Angiography After Cardiac Arrest Without ST Elevation - 18 day(s) ago

      This individual patient data meta-analysis examines the association of immediate vs delayed or selective coronary angiography in patients with out-of-hospital cardiac arrest without ST-segment elevation with 1-year survival outcomes.

      Source: jamanetwork.com
      Categories: General Medicine News, Expert Picks
      Tweet Tweets with this article
      • Profile photo of 	CMichaelGibson
        CMichaelGibson

        Immediate Coronary Angiography After Cardiac Arrest Without ST Elevation: showed no benefit over delayed or selective strategies for survival up to 1 year posthospitalization. https://t.co/Zr8C4ADn2N

    Load More

    C. Michael Gibson MD

    @CMichaelGibson

    Non-Profit Founder/Leader | ❤️ Doc | Artist | Scientist | Educator | Med News Anchor https://t.co/LDrNxgwhA4 | RT ≠ endorse | Disclaimer here: https://t.co/2jtJQZQU0H

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings